Skip to Main Content

Paper Details

MerTK as a therapeutic target in glioblastoma.
Neuro Oncol
57
2018
/, CD206, CD206+, CD206+ macrophages, CD68, CD68+ macrophages, GAMs, GBM, Glioma-associated macrophages and, MerTK, UNC2025, glial fibrillary acidic protein, glioblastoma, macrophages, mice, microglia, mouse, patient, receptor tyrosine kinase, recurrent tumors, tumor, tumor cells, tyrosine
Author NameAffiliation
Ryan E BashLineberger Comprehensive Cancer Center.
Ryan E Bash
Ryan E BashLineberger Comprehensive Cancer Center.
Ryan E Bash
Erik P SulmanUniversity of Texas MD Anderson Cancer Center
Erik P SulmanUniversity of Texas MD Anderson Cancer Center
Christopher Ryan MillerLineberger Comprehensive Cancer Center.
Christopher Ryan Miller
Christopher Ryan Miller
Christopher Ryan MillerLineberger Comprehensive Cancer Center.
Christopher Ryan Miller
Christopher Ryan Miller
  • 1 - 12

Datasets

Release 1.2